Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm"
- PMID: 32468246
- DOI: 10.1007/s00428-020-02844-2
Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm"
Abstract
Cases of "pancreatic ductal adenocarcinoma (PDAC) concomitant with intraductal papillary mucinous neoplasm" (IPMN) have multiple PDAC lesions more frequently than cases of "PDAC without IPMN". However, the mechanism of carcinogenesis in this former disease category remains unknown. The main objective of this work was thus to investigate the effects of chronic inflammation on carcinogenesis in PDAC cases. We selected 31 "PDAC concomitant with IPMN" patients and 58 "PDAC without IPMN" patients and pathologically evaluated their background pancreatic parenchyma. Fibrosis and inflammation scores of background pancreas were higher in "PDAC concomitant with IPMN" than in "PDAC without IPMN" (P < 0.0001 and P < 0.0001, respectively), whereas the fatty infiltration score of background pancreas was high in "PDAC without IPMN" (P = 0.0024). Immunohistochemically, the expression of 8-hydroxy-2'-deoxyguanosine (8-OHDG), an oxidative stress marker, in the background pancreas was high in "PDAC concomitant with IPMN" compared with that in "PDAC without IPMN" (P < 0.0001). Chronic inflammation activates oxidative stress in tissue throughout the pancreas and probably confers susceptibility to tumorigenesis in "PDAC concomitant with IPMN".
Keywords: 8-Hydroxy-2′-deoxyguanosine; Chronic inflammation; Intraductal papillary mucinous neoplasm; Oxidative stress; Pancreatic ductal adenocarcinoma.
Similar articles
-
Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.Pancreas. 2013 Nov;42(8):1267-74. doi: 10.1097/mpa.0b013e3182954137. Pancreas. 2013. PMID: 24308063
-
Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.Ann Surg. 2020 May;271(5):941-948. doi: 10.1097/SLA.0000000000003060. Ann Surg. 2020. PMID: 30308608
-
Pancreatic inflammation and atrophy are not associated with pancreatic cancer concomitant with intraductal papillary mucinous neoplasm.Pancreatology. 2018 Jan;18(1):54-60. doi: 10.1016/j.pan.2017.12.007. Epub 2017 Dec 16. Pancreatology. 2018. PMID: 29269290
-
Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.J Hepatobiliary Pancreat Sci. 2015 Jul;22(7):519-23. doi: 10.1002/jhbp.246. Epub 2015 Apr 21. J Hepatobiliary Pancreat Sci. 2015. PMID: 25900667 Review.
-
Malignant potential of intraductal papillary mucinous neoplasms of the pancreas.Surg Today. 2010 Sep;40(9):816-24. doi: 10.1007/s00595-009-4227-y. Epub 2010 Aug 26. Surg Today. 2010. PMID: 20740343 Review.
Cited by
-
A Novel Scoring System to Improve the Detection Efficiency of Pancreatic Cystic Lesions in the General Population.Intern Med. 2023 Feb 1;62(3):335-344. doi: 10.2169/internalmedicine.9104-21. Epub 2022 Jul 14. Intern Med. 2023. PMID: 35831108 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical